Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
Accenture
Farmers Insurance
Healthtrust
Chinese Patent Office
Cerilliant
Fuji
Boehringer Ingelheim
Daiichi Sankyo
Julphar

Generated: October 21, 2017

DrugPatentWatch Database Preview

Braeburn Pharms Inc Company Profile

« Back to Dashboard

What is the competitive landscape for BRAEBURN PHARMS INC, and what generic alternatives to BRAEBURN PHARMS INC drugs are available?

BRAEBURN PHARMS INC has one approved drug.

There is one US patent protecting BRAEBURN PHARMS INC drugs.

There are ten patent family members on BRAEBURN PHARMS INC drugs in seven countries.

Summary for Applicant: Braeburn Pharms Inc

International Patents:10
US Patents:1
Tradenames:1
Ingredients:1
NDAs:1
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Braeburn Pharms Inc
PROBUPHINE
buprenorphine hydrochloride
IMPLANT;IMPLANTATION204442-001May 26, 2016RXYesYes► Subscribe► Subscribe► Subscribe
Braeburn Pharms Inc
PROBUPHINE
buprenorphine hydrochloride
IMPLANT;IMPLANTATION204442-001May 26, 2016RXYesYes► Subscribe► Subscribe ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Braeburn Pharms Inc Drugs

Country Document Number Estimated Expiration
Australia2008212011► Subscribe
European Patent Office1509182► Subscribe
Australia2003240493► Subscribe
European Patent Office2561860► Subscribe
World Intellectual Property Organization (WIPO)03101358► Subscribe
New Zealand536965► Subscribe
Japan2005528422► Subscribe
Canada2487577► Subscribe
MexicoPA04011875► Subscribe
Japan4668611► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Chubb
Novartis
QuintilesIMS
Express Scripts
Fuji
Mallinckrodt
Medtronic
Deloitte
Healthtrust
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot